Dgh. Livermore et al., SYNTHESIS AND ANTI-HIV-1 ACTIVITY OF A SERIES OF IMIDAZO[1,5-B]PYRIDAZINES, Journal of medicinal chemistry, 36(24), 1993, pp. 3784-3794
A series of substituted imidazo[1,5-b]pyridazines have been prepared a
nd tested for inhibitory activity against the reverse transcriptase of
HIV-1 (RT) and their ability to inhibit the growth of infected MT-4 c
ells. Crystal data are reported on two compounds, 15c and 33. From the
structure-activity relationships developed within this and other seri
es, it is proposed that key features of the interaction with RT includ
e hydrogen-bond acceptor and aromatic pi-orbital bonding with the imid
azopyridazine nucleus and a benzoyl function separated from the hetero
cycle by a suitable spacer group. Exceptional activity against the rev
erse transcriptase of HIV-1 (IC50 = 0.65 nM) was obtained with a 2-imi
dazolyl-substituted derivative, midazo-[1,5-b]pyridazin-7-yl]-1-phenyl
-1-heptanone (33) which is attributed to additional binding of the imi
dazole sp(2) nitrogen atom. A number of the compounds in this series a
lso inhibit the replication of HIV-1 in vitro in MT-4 and C8166 cells
at levels observed with the nucleoside AZT.